Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

New York state guide · NYRx drug list revised Oct 22, 2026

Does Medicaid Cover Wegovy in New York, or Zepbound and Ozempic?

Only in narrow cases. NYRx covers Wegovy for heart disease and Zepbound for sleep apnea, each at a BMI of 40 or higher, two attempts per lifetime. Weight loss alone is never covered.

What to do next

  • Medicaid: check which diagnoses it covers; if one fits, ask your doctor to request prior authorization.
  • Medicare: ask your prescriber about the GLP-1 Bridge.
  • State employee or job-based plan: call the number on your insurance card.

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

Coverage in New York at a glance

Medicaid
Weight loss alone: excluded by regulation
  • Wegovy and Zepbound: BMI 40+ only

Source: NYRx, the Medicaid Drug Program, checked Nov 9, 2026 · Rules

State employees
Empire Plan: Wegovy and Zepbound with PA

Source: NY Department of Civil Service, NYSHIP, checked Nov 9, 2026 · Rules

Medicare
$50 Bridge copay

Source: CMS, checked Nov 9, 2026 · Rules

By GLP1-US Editorial TeamUpdated

01 Medicaid

Does Medicaid Cover Wegovy and Zepbound in New York?

New York's Medicaid rules start from a flat exclusion. Section 505.3(g)(3) of Title 18 of the New York Codes, Rules and Regulations says: "No payment will be made for any drug which has weight reduction as its sole clinical use." Wegovy and Zepbound have other FDA-approved uses, and the NYRx drug list revised October 22, 2026 covers them for exactly those uses, with criteria stricter than the FDA labels.

Wegovy (semaglutide)

PA

  • Diagnosis of cardiovascular disease
  • BMI of 40 kg/m² or higher
  • Taking part in lifestyle changes that support heart health
  • Lifetime limit: two treatment attempts

Zepbound (tirzepatide)

PA

  • Diagnosis of obstructive sleep apnea
  • BMI of 40 kg/m² or higher
  • Taking part in lifestyle changes
  • Lifetime limit: two treatment attempts

The FDA labels are broader: Wegovy's heart indication covers adults with established cardiovascular disease and overweight or obesity, and Zepbound's sleep apnea indication covers adults with obesity. NYRx sets its own BMI floor of 40. Saxenda and Foundayo, which are approved only for weight management, do not appear on the NYRx list. See how other states handle Medicaid coverage. Rules next door: New Jersey and Pennsylvania.

What you pay on NYRx: $1 per prescription for generics and preferred brands, $3 for non-preferred brands, and no more than $50 in Medicaid copays per quarter ($200 a year). If you cannot pay because of hardship, the pharmacy still gives you the drug (NYRx member pharmacy page, checked Nov 9, 2026). When NYRx says no, the cash prices below apply; Medicare members can use the $50 Bridge.

02 Diabetes

NY Medicaid GLP-1s for Type 2 Diabetes

For diabetes, the picture is ordinary. The NYRx class "GLP-1 Receptor Agonists, Type 2 Diabetes" has a clinical criterion: the prescriber confirms an FDA-approved or compendia-supported indication that Medicaid covers. Non-preferred drugs need prior authorization.

PreferredNon-preferred (PA required)
exenatidegeneric liraglutide
Ozempic penMounjaro
TrulicityOzempic tablets
Victoza (brand preferred over generic)Rybelsus
Soliqua, Xultophy

NYRx also requires prior authorization if you take a GLP-1 and a DPP-4 inhibitor (such as sitagliptin) at the same time. Ozempic prescribed only for weight loss falls under the 505.3(g)(3) exclusion.

NYRx, the Medicaid Drug Program, Preferred Drug List revised Oct 22, 2026; 18 NYCRR 505.3(g). Checked Nov 9, 2026.

03 Who is covered

Which New Yorkers This Applies To

Since April 1, 2023, members of Mainstream Medicaid Managed Care plans, Health and Recovery Plans (HARPs) and HIV Special Needs Plans get prescriptions through NYRx, not through their health plan. So the rules above apply whether you are in fee-for-service Medicaid or a managed care plan.

Coverage typeDrug list used
Fee-for-service MedicaidNYRx list
Mainstream Managed Care, HARP, HIV-SNPNYRx list
Managed Long Term Care (PACE, MAP, MLTC)plan's own list
Essential Planplan's own list

If you are in the Essential Plan or a long-term care plan, ask that plan for its formulary; NYRx criteria do not decide your coverage.

04 State employees

NY State Employees: Empire Plan Coverage

The Empire Plan, the main NYSHIP plan for state and many public employees, lists Wegovy and Zepbound as preferred anti-obesity drugs with prior authorization on its 2026 Advanced Flexible Formulary (July 2026 edition). Generic liraglutide and Contrave are preferred with PA too; Qsymia is non-preferred (Level 3) with PA. Foundayo is not listed in the July 2026 edition.

Copays

Preferred brand drugs generally take the Level 2 copay and non-preferred brands Level 3; your exact copay depends on your union or employer group. The formulary does not publish the BMI criteria for the PA.

How to check your own coverage:

  1. 1Log in at empireplanrxprogram.com and search the drug.
  2. 2Or call 1-877-7-NYSHIP (1-877-769-7447) and choose option 4 for the prescription program.
  3. 3Ask your prescriber to submit the prior authorization before the first fill.
  4. 4If you are in a NYSHIP HMO instead of the Empire Plan, use that HMO's drug list.

Private and employer plans set their own GLP-1 rules, so check your plan's formulary. See GLP-1 cost with insurance for how plan coverage usually works.

05 Medicare

Medicare in New York: the $50 GLP-1 Bridge

There is no New York-specific Medicare rule for GLP-1s. The federal Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027 and charges $50 a month for every Wegovy form (pen, Wegovy HD and pill), the Zepbound KwikPen (not vials) and Foundayo. Ozempic and Mounjaro are not part of it.

TierBMI at start of GLP-1 therapyAlso required
135 or higherNothing else
230 or higherHFpEF, uncontrolled hypertension or CKD stage 3a or higher
327 or higherPrediabetes, prior heart attack, prior stroke or symptomatic PAD

That makes Medicare far easier than NYRx for New Yorkers with both: a BMI of 35 qualifies for the Bridge, while NYRx needs 40 plus a diagnosis. Details in our Medicare GLP-1 Bridge guide; Part D and Medicare Advantage rules outside the Bridge are in Medicare GLP-1 coverage.

06 Cash prices

Cash Prices in New York

Self-pay prices are set nationally by the manufacturers; no New York program sets its own GLP-1 price. Prices below are as of November 2026 and may change.

Wegovy pill

$149 (1.5 mg) to $299 a month · NovoCare

Wegovy pen

$199 for the first 2 fills, then $349; Wegovy HD $399 · NovoCare. See Wegovy cost.

Zepbound vials or KwikPen

$299 / $399 / $449 by dose, refill within 45 days · LillyDirect. See Zepbound cost.

Foundayo

from $149 a month · LillyDirect. See Foundayo.

The $199 Wegovy starter price applies to new NovoCare patients through Dec 31, 2026. Full comparison, including TrumpRx and Costco, in our GLP-1 cost guide. Lowest-priced online routes, including compounded options that are not FDA-approved: cheapest GLP-1 online.

07 Telehealth

Telehealth Providers That Serve New York

The matrix shows which online clinics prescribe in New York; check that the clinic lists New York among the states it serves before you book.

Online GLP-1 programs that say they serve New York, Oct 2026
ProgramInsurance
PlushCare
Copay (typically $30 or less) or $129 self-pay
All 50 states and DC (help center). FDA-approved brands, filled at your pharmacy.
Takes insurance
Sesame Care
From $37 per visit, or $59/mo (annual) to $99/mo membership
Names NY as served; labs not included in NY. Visit-based; labs billed separately in NY.
Limited
Mochi Health
Health membership $79/mo ($0 first month for new members) or $49/mo on a 12-month plan; with qualifying insurance, membership from $17/mo plus $0 to $30 visit copays
Anywhere in the US (FAQ). Medication availability and price vary by state.
Takes insurance
Found
$79 to $289/mo (insurance track) or $149 to $339/mo (cash track, medication included)
Insurance map lists 42 states, this one included. Some prescriptions not available in all states.
Takes insurance
Calibrate
$199/mo membership, 3-month minimum ($597)
All 50 states and DC (FAQ). Brand GLP-1s billed to insurance.
Takes insurance
MEDvidi
$195 initial, $159 follow-up; weight-loss package $249
Named in its list of 35 states. Some states require an in-person visit.
Cash only
IvyRx
Free consultation
All 50 states (help center, Dec 2024). Compounded semaglutide.
Cash only
Eden
Included (no membership fees)
GLP-1 programs in all 50 states (FAQ). Compounded only.
Cash only
Enhance.MD
Bundled
Named in its launch-state list (FAQ). Compounded semaglutide.
Cash only
ShedRx
Bundled
All 50 states (FAQ). Treatment availability varies by state.
Cash only

10 programs whose own site states they serve New York, state lists re-read Oct 23, 2026. Programs that publish no state list (including Ro, Hims, Henry Meds and WeightWatchers) are not shown; that does not mean they are unavailable. Amazon One Medical lists weight care in 48 states and DC without naming the two excluded states.

08 Help

Where to Get Help in New York

New York Medicaid Helpline

(800) 541-2831, TTY 1-800-662-1220, Monday to Friday 8 am to 8 pm, Saturday 9 am to 1 pm. It answers member questions about pharmacy benefits, in several languages.

NYRx Clinical Call Center (for prescribers)

1-877-309-9493. NYRx also accepts electronic prior authorizations through CoverMyMeds.

HIICAP (Health Insurance Information Counseling and Assistance Program)

New York's free Medicare counseling, run by the State Office for the Aging, with more than 700 trained counselors in local offices for the aging.

Empire Plan prescription program

1-877-7-NYSHIP, option 4.

09 FAQ

New York GLP-1 Coverage FAQ

Does Medicaid cover Wegovy in New York?
Only for heart risk. NYRx approves Wegovy when you have a cardiovascular disease diagnosis, a BMI of 40 or higher and you are taking part in heart-healthy lifestyle changes. You get two treatment attempts in a lifetime. Wegovy for weight loss alone is not covered, because state regulation bars payment for drugs whose sole use is weight reduction.
Does Medicaid cover Zepbound in New York?
Only for obstructive sleep apnea. The NYRx list revised October 22, 2026 requires an OSA diagnosis, a BMI of 40 or higher, lifestyle changes and allows two treatment attempts per lifetime. Without coverage, Zepbound KwikPen or vials cost $299 to $449 a month through LillyDirect as of November 2026.
Does New York Medicaid cover Ozempic?
Yes, for type 2 diabetes. The Ozempic pen is a preferred drug on the NYRx list; Ozempic tablets, Mounjaro and Rybelsus are non-preferred and need prior authorization. Combining a GLP-1 with a DPP-4 inhibitor also triggers PA. Ozempic prescribed only to lose weight is excluded under 18 NYCRR 505.3(g)(3).
Does the Empire Plan cover Wegovy and Zepbound?
Yes, with prior authorization. The 2026 Empire Plan Advanced Flexible Formulary (July edition) lists both as preferred anti-obesity drugs, alongside generic liraglutide and Contrave. Copays follow your group's Level 2 brand tier. The formulary does not show the PA criteria, so check empireplanrxprogram.com or call 1-877-769-7447, option 4.
I have Medicaid and Medicare in New York. Which pays?
For weight management, the Medicare GLP-1 Bridge is usually the realistic route: $50 a month for Wegovy, the Zepbound KwikPen or Foundayo if your starting BMI is 35 or higher, or 27 or higher with a listed condition. NYRx requires a BMI of 40 plus heart disease or sleep apnea. HIICAP counselors can review your specific plans for free.

10 Other states

GLP-1 Coverage in Other States

All 50 states and DC side by side: Medicaid GLP-1 coverage by state. National background: does Medicaid cover weight loss shots. On an employer plan or Medicare instead of Medicaid? Rules by insurer: Medicare, Blue Cross Blue Shield, UnitedHealthcare, Aetna, Cigna, Kaiser Permanente.

Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

Checked against primary sources such as FDA labels, CMS and provider pages
Updated
How we check facts →